Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)

Inovio Pharmaceuticals, Inc. (AMEX:INO) entered into an office lease (the “Lease”) with a publicly owned real estate investment trust, located in Plymouth Meeting, Pennsylvania. We expect to occupy the space commencing in the third quarter of 2014. The initial term of the lease is eleven and one-half years. We intend to use the facility for office purposes. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was 3.53% … Continue reading Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)

Jason Knox03/1103/11

Biotech Stocks Touching New Highs: Northwest Biotherapeutics (NASDAQ:NWBO), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Emergent Biosolutions (NYSE:EBS), Xencor (NASDAQ:XNCR)

CRT Capital Thursday morning ratings report included a coverage initiation by analyst Arlinda Lee on Oncogenex Pharmaceuticals (NASDAQ: OGXI) with a Buy rating and price target of $20. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) rose 8.88 percent to $13.85 yesterday on volume of 483,342million shares. The intra-day range of the stock was $12.61 to $13.95. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) has a market capitalization of $203.70million. Emergent Biosolutions … Continue reading Biotech Stocks Touching New Highs: Northwest Biotherapeutics (NASDAQ:NWBO), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Emergent Biosolutions (NYSE:EBS), Xencor (NASDAQ:XNCR)

John Meady03/1103/11

Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small US biotechnology company has not yet completed its late-stage trial of the immunotherapy. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at $7.85. Traded volume was 6,155,092 million shares in the last … Continue reading Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

Richard Atkins03/1103/11

Hot News : Yahoo! Inc. (NASDAQ:YHOO), Ford Motor Co. (NYSE:F), Tesoro Logistics LP (NYSE:TLLP), Northwest Biotherapeutics, Inc. (NASDAQ:NWBO), AudioCodes Ltd. (NASDAQ:AUDC)

Yahoo! Inc. (NASDAQ:YHOO) is making amends for years of blundering with one smart move: an early investment in China’s Alibaba Group that has turned into a multibillion-dollar boon. Yahoo! Inc. (NASDAQ:YHOO) belongs to Technology sector. Its net profit margin is 26.50% and weekly performance is 2.30%. On last trading day company shares ended up $42.08. Yahoo! Inc. (NASDAQ:YHOO) distance from 50-day simple moving average (SMA50) … Continue reading Hot News : Yahoo! Inc. (NASDAQ:YHOO), Ford Motor Co. (NYSE:F), Tesoro Logistics LP (NYSE:TLLP), Northwest Biotherapeutics, Inc. (NASDAQ:NWBO), AudioCodes Ltd. (NASDAQ:AUDC)

John Meady09/1909/19

Why Need to Watch : Northwest Biotherapeutics (NASDAQ:NWBO), Akamai Technologies (NASDAQ:AKAM), Marathon Petroleum (NYSE:MPC), Learning Tree (NASDAQ:LTRE), Gramercy Property Trust (NYSE:GPT)

Northwest Biotherapeutics Inc. (NASDAQ:NWBO) (“NW Bio”) on 14 Aug 2014 announced the pricing of $17.5 million aggregate principal amount of its unsecured convertible notes (the “Notes”) in a private placement.The Notes are initially convertible at $7.30 per share a 10% premium above the closing market price of $6.64 per share on August 13 2014.NW Bio plans to use the offering proceeds to fund new manufacturing … Continue reading Why Need to Watch : Northwest Biotherapeutics (NASDAQ:NWBO), Akamai Technologies (NASDAQ:AKAM), Marathon Petroleum (NYSE:MPC), Learning Tree (NASDAQ:LTRE), Gramercy Property Trust (NYSE:GPT)

Colin Pettis08/2008/20

Gainers at Biotech: Alcobra (NASDAQ:ADHD), Aratana Therapeutics (NASDAQ:PETX), Northwest Biotherapeutics (NASDAQ:NWBO), Agenus Inc (NASDAQ:AGEN), AEterna Zentaris (NASDAQ:AEZS)

Research analysts at WBB Securities initiated coverage on shares of Alcobra Ltd (NASDAQ:ADHD) in a report released on Thursday, 26 June 2014. The firm set a “hold” rating and a $18.00 price target on the stock. WBB Securities’ target price points to a potential upside of 5.76% from the company’s current price. Alcobra Ltd (NASDAQ:ADHD) stock performance was 5.85% in last session and finished the … Continue reading Gainers at Biotech: Alcobra (NASDAQ:ADHD), Aratana Therapeutics (NASDAQ:PETX), Northwest Biotherapeutics (NASDAQ:NWBO), Agenus Inc (NASDAQ:AGEN), AEterna Zentaris (NASDAQ:AEZS)

Jayne Crisman07/0307/03